These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8792761)

  • 1. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis.
    Aronson R; Offman HJ; Joffe RT; Naylor CD
    Arch Gen Psychiatry; 1996 Sep; 53(9):842-8. PubMed ID: 8792761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.
    Joffe RT; Singer W; Levitt AJ; MacDonald C
    Arch Gen Psychiatry; 1993 May; 50(5):387-93. PubMed ID: 8489327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies.
    Bauer M; Dopfmer S
    J Clin Psychopharmacol; 1999 Oct; 19(5):427-34. PubMed ID: 10505584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination therapies in antidepressive drug refractory depression--an overview].
    Schmauss M; Erfurth A
    Fortschr Neurol Psychiatr; 1996 Oct; 64(10):390-402. PubMed ID: 9036099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricyclic drugs for depression in children and adolescents.
    Hazell P; O'Connell D; Heathcote D; Henry D
    Cochrane Database Syst Rev; 2000; (3):CD002317. PubMed ID: 10908557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature.
    Altshuler LL; Bauer M; Frye MA; Gitlin MJ; Mintz J; Szuba MP; Leight KL; Whybrow PC
    Am J Psychiatry; 2001 Oct; 158(10):1617-22. PubMed ID: 11578993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open study of triiodothyronine augmentation of tricyclic antidepressants in inpatients with refractory depression.
    Birkenhäger TK; Vegt M; Nolen WA
    Pharmacopsychiatry; 1997 Jan; 30(1):23-6. PubMed ID: 9065966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials.
    Crossley NA; Bauer M
    J Clin Psychiatry; 2007 Jun; 68(6):935-40. PubMed ID: 17592920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation strategies in depression 2000.
    Nelson JC
    J Clin Psychiatry; 2000; 61 Suppl 2():13-9. PubMed ID: 10714619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of refractory primary depression].
    van Praag HM
    Ned Tijdschr Geneeskd; 1997 Jul; 141(28):1375-9. PubMed ID: 9380197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T3 and lithium potentiation of tricyclic antidepressants.
    Joffe RT
    Am J Psychiatry; 1988 Oct; 145(10):1317-8. PubMed ID: 3138921
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.
    Goodwin FK; Prange AJ; Post RM; Muscettola G; Lipton MA
    Am J Psychiatry; 1982 Jan; 139(1):34-8. PubMed ID: 7055275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation.
    Garbutt JC; Mayo JP; Gillette GM; Little KY; Mason GA
    Am J Psychiatry; 1986 Aug; 143(8):1038-9. PubMed ID: 3089033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression.
    Nelson JC; Baumann P; Delucchi K; Joffe R; Katona C
    J Affect Disord; 2014 Oct; 168():269-75. PubMed ID: 25069082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological choices after one antidepressant fails: a survey of UK psychiatrists.
    Shergill SS; Katona CL
    J Affect Disord; 1997 Mar; 43(1):19-25. PubMed ID: 9127827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What role do atypical antipsychotic drugs have in treatment-resistant depression?
    Thase ME
    J Clin Psychiatry; 2002 Feb; 63(2):95-103. PubMed ID: 11874227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium augmentation of antidepressants in treatment-refractory depression.
    Heit S; Nemeroff CB
    J Clin Psychiatry; 1998; 59 Suppl 6():28-33; discussion 34. PubMed ID: 9674934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Augmentation strategies for therapy resistant depression - a review].
    Schmauss M; Messer T
    Psychiatr Prax; 2007 May; 34(4):165-74. PubMed ID: 17160747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the duration for augmentation with T3 or lithium in resistant depression?
    Price LH
    J Clin Psychopharmacol; 1989 Feb; 9(1):73. PubMed ID: 2708563
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.
    Nierenberg AA; Fava M; Trivedi MH; Wisniewski SR; Thase ME; McGrath PJ; Alpert JE; Warden D; Luther JF; Niederehe G; Lebowitz B; Shores-Wilson K; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1519-30; quiz 1665. PubMed ID: 16946176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.